Mp43-01 phase 2 keynote-057 study: pembrolizumab for patients with high-risk non–muscle invasive bladder cancer unresponsive to bacillus calmette-guerin
Journal of Urology(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Urology(2019)